.svg)
Total Testosterone: The Full Circulating Androgen Pool
Total testosterone is a blood measurement of the overall amount of the sex hormone testosterone circulating in your body. Testosterone is a steroid hormone (an androgen) made primarily in the testes (Leydig cells) and, in all sexes, in smaller amounts by the ovaries and adrenal glands (adrenal cortex). In blood, most testosterone travels attached to carrier proteins—sex hormone–binding globulin (SHBG) and albumin—with a small fraction unbound (“free”). A total measurement adds up the protein‑bound and free portions to represent the body’s total circulating testosterone.
Testosterone acts as a chemical signal that guides sexual development, supports libido and fertility, and helps maintain muscle mass, bone strength, and red blood cell production. It also influences body composition, hair and skin oil production, energy, and mood by turning genes on and off through the androgen receptor. A total testosterone result reflects how much androgen your body is producing and delivering to tissues at a given time, integrating output from the gonads and adrenals and regulation by the brain’s hypothalamic‑pituitary‑gonadal (HPG) axis.
Why Total Testosterone Is the First-Line Androgen Snapshot
Total testosterone measures all circulating testosterone—both protein-bound and free—and reflects the body’s androgen signal that drives sexual function, fertility, muscle and bone integrity, red blood cell production, mood, and metabolism. Because binding proteins shift with age, weight, thyroid, and liver status, the test offers a systems snapshot.
Big picture, total testosterone links the hypothalamic-pituitary-gonadal axis with liver-derived SHBG, adrenal input, and metabolic health. Persistently abnormal values associate with osteoporosis, anemia, infertility, and metabolic dysfunction; pairing total with free testosterone, SHBG, and LH/FSH gives the clearest view.
How a Total Testosterone Result Maps Across Sex and Age
Adult men typically range about 300–1000, adult women about 15–70, with wide swings in puberty; pregnancy raises total values via higher SHBG. Most people function well within the reference range, often near the middle; numbers at the extremes carry physiologic costs.
When levels are low, men may have reduced testicular output or pituitary signaling, with low libido, erectile difficulties, fatigue, low mood, loss of muscle, more fat, anemia, and bone loss—shaping energy, endurance, and intimacy. In teens this can delay puberty. In women, very low androgens can mean lower sexual desire, reduced vitality, and decreased bone and lean mass, though interpretation is nuanced.
High levels in men often reflect androgen use or, rarely, tumors; consequences include acne, irritability, elevated hematocrit, and reduced fertility from HPG-axis suppression. Excess in boys can accelerate puberty. In women, elevated testosterone suggests ovarian or adrenal hyperandrogenism (such as PCOS or nonclassic CAH), causing hirsutism, acne, scalp hair thinning, irregular periods, infertility, and increased metabolic risk.
What Shifts a Total Testosterone Value
Notes: Testosterone is diurnal (morning samples are highest). SHBG alters totals—rising with age, pregnancy, liver or thyroid disease, and oral estrogens; falling with obesity and insulin resistance. Total may not reflect bioavailable hormone; free or calculated free testosterone and accurate assays (mass spectrometry) improve interpretation.
What a Total Testosterone Number Tells You About Androgen Health
Total testosterone measures all testosterone in blood—both freely circulating and bound to carrier proteins (SHBG and albumin). As the body’s principal androgen, it influences energy and motivation, muscle and bone building (anabolism), red blood cell production, fat distribution, insulin sensitivity, libido and fertility, and aspects of mood and cognition.
Low values usually reflect reduced production (testicular, ovarian, or adrenal), reduced pituitary signaling, or increased binding that lowers bioavailable hormone (high SHBG). In men this often appears as low energy and libido, erectile difficulty, decreased muscle, increased fat, anemia, and lower bone density. In women, low levels are less clearly defined but can align with reduced sexual desire and vitality. Levels decline with age; acute illness, obesity, opioids, and glucocorticoids can lower testosterone.
Being in range suggests appropriate androgen availability for sex and age, supporting stable reproductive function, body composition, hematopoiesis, and mental/physical drive. In asymptomatic adult men, functional well-being often aligns with mid-range totals; in women, normal sits much lower while supporting menstrual regularity and metabolic balance.
High values usually reflect increased production or exogenous androgens; pregnancy raises SHBG, which can elevate total even when free is normal or low. In men, very high levels can cause acne, oily skin, increased red cell mass (erythrocytosis), mood changes, and reduced fertility from suppressed gonadotropins; rarely, tumors are responsible. In women, high levels often indicate ovarian/adrenal hyperandrogenism (e.g., PCOS or adrenal disorders) with irregular cycles, hirsutism, acne, or virilization.
FAQs
It measures total testosterone (free, albumin-bound, SHBG-bound) in your blood to assess androgen status.
It clarifies hormone status related to libido, strength, recovery, body composition, mood, and fertility.
Frequency depends on goals. Many people test in the morning and repeat every 3–6 months for trend tracking.
Age, SHBG shifts, illness, thyroid status, body composition, liver disease, oral estrogens, medications, and training load.
A morning draw is preferred. Fasting is not usually required unless paired with other labs.
Superpower currently offers at-home blood testing in the following states: Alabama, Arizona, California, Colorado, Connecticut, Delaware, District of Columbia, Florida, Georgia, Idaho, Illinois, Indiana, Kansas, Maine, Maryland, Massachusetts, Michigan, Minnesota, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, South Carolina, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, and Wisconsin.
We’re actively expanding nationwide, with new states being added regularly. If your state isn’t listed yet, stay tuned.
References
- Bhasin, S., Brito, J. P., Cunningham, G. R., Hayes, F. J., Hodis, H. N., Matsumoto, A. M., Snyder, P. J., Swerdloff, R. S., Wu, F. C., & Yialamas, M. A. (2018). Testosterone therapy in men with hypogonadism: An Endocrine Society clinical practice guideline. The Journal of Clinical Endocrinology and Metabolism, 103(5), 1715-1744. https://doi.org/10.1210/jc.2018-00229
- Travison, T. G., Vesper, H. W., Orwoll, E., Wu, F., Kaufman, J. M., Wang, Y., Lapauw, B., Fiers, T., Matsumoto, A. M., & Bhasin, S. (2017). Harmonized reference ranges for circulating testosterone levels in men of four cohort studies in the United States and Europe. The Journal of Clinical Endocrinology and Metabolism, 102(4), 1161-1173. https://doi.org/10.1210/jc.2016-2935
- Selby, C. (1990). Sex hormone binding globulin: Origin, function and clinical significance. Annals of Clinical Biochemistry, 27(6), 532-541. https://doi.org/10.1177/000456329002700603
- Stener-Victorin, E., Teede, H., Norman, R. J., Legro, R., Goodarzi, M. O., Dokras, A., Laven, J., Hoeger, K., & Piltonen, T. T. (2024). Polycystic ovary syndrome. Nature Reviews Disease Primers, 10(1), 27. https://doi.org/10.1038/s41572-024-00511-3
- Gasbarrino, K., Daly, E., & Daskalopoulou, S. S. (2022). An LC-MS/MS methodological framework for steroid hormone measurement from human serum. Hormone and Metabolic Research, 54(5), 300-307. https://doi.org/10.1055/a-1768-0709
.avif)
.svg)
.svg)
